Background Evaluating a new endovascular treatment for intracranial aneurysms must not only demonstrate short-term safety and efficacy, but also evaluate longer-term outcomes (eg, delayed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback